#1
#1 out of 1
health13h ago
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026
- Mount Sinai Health System to adopt SOPHiA DDM to enhance cancer genomics research and testing.
- Platform to boost NGS workflow for blood cancers and solid tumors at Mount Sinai.
- The collaboration aims to improve interpretation speed and patient care.
- SOPHiA GENETICS promotes AI-driven precision medicine through its platform.
- The announcement came during AACR 2026 in San Diego.
- Mount Sinai emphasizes leadership in AI and data-driven oncology.
- Mount Sinai will use SOPHiA DDM for broader genomic interpretation.
- SOPHiA GENETICS aims to democratize data-driven medicine globally.
- The collaboration involves SOPHiA DDM for Blood Cancers and Solid Tumors.
- SOPHiA GENETICS notes the platform reduces manual interpretation time.
Vote 0